# Trade Mark Journal No.2025/049 5 December 2025

## WO0000001887696 (5)

Office of origin: United States of America

Date of International Registration:23 October 2025
Date of designation in the UK: 23 October 2025

International priority date claimed: 24 April 2025 (United States of America) (99153704)

Class 5
  Pharmaceutical preparations for the treatment of bipolar disorder.

LB Pharmaceuticals Inc.

Representative: Winfield B. Martin Perkins Coie LLP, P.O. Box 2608, Seattle WA 98111, UNITED STATES OF AMERICA